clinical trial · NCT06153498
PK/PD Properties and Safety of Remazolam Besylate for Injection in ICU Patients With Impaired Renal Function
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology·phase2·unknown·n = 36
Mechanically Ventilated PatientsRemimazolam besylate
brief summary
Pharmacokinetic/pharmacodynamic profiles of remazolam besylate were compared in patients with impaired and normal renal function in the ICU, and safety was assessed by recording hemodynamic parameters and adverse events.
started
Nov 4, 2023
primary completion
Dec 1, 2024
completion
Dec 1, 2024
last updated
Dec 13, 2023
official title
A Randomized Study of the PK/PD Properties and Safety of Remazolam Besylate for Injection in ICU Patients With Impaired Renal Function
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol